ATC code R03

ATC codes

R06 Antihistamines for systemic use

R07 Other respiratory system products

ATC code R03 Drugs for obstructive airway diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup R03 is part of the anatomical group R Respiratory system.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR03.^[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

R03A Adrenergics, inhalants

R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

R03AK01 Epinephrine and other drugs for obstructive airway diseases

R03AK02 Isoprenaline and other drugs for obstructive airway diseases

R03AK04 Salbutamol and sodium cromoglicate

R03AK05 Reproterol and sodium cromoglicate

R03AK06 Salmeterol and fluticasone

R03AK07 Formoterol and budesonide

R03AK08 Formoterol and beclometasone

R03AK09 Formoterol and mometasone

R03AK10 Vilanterol and fluticasone furoate

R03AK11 Formoterol and fluticasone

R03AK12 Salmeterol and budesonide

R03AL Adrenergics in combination with anticholinergics

R03AL01 Fenoterol and ipratropium bromide

R03AL02 Salbutamol and ipratropium bromide

R03AL03 Vilanterol and umeclidinium bromide

R03AL04 Indacaterol and glycopyrronium bromide

R03AL05 Formoterol and aclidinium bromide

R03AL06 Olodaterol and tiotropium bromide

R03B Other drugs for obstructive airway diseases, inhalants

R03BA Glucocorticoids

R03BA01 Beclometasone

R03BA02 Budesonide

R03BA03 Flunisolide

R03BA04 Betamethasone

R03BA05 Fluticasone

R03BA06 Triamcinolone

R03BA07 Mometasone

R03BA08 Ciclesonide

R03BA09 Fluticasone furoate

R03BB Anticholinergics

R03BB01 Ipratropium bromide

R03BB02 Oxitropium bromide

R03BB03 Stramoni preparations

R03BB04 Tiotropium bromide

R03BB05 Aclidinium bromide

R03BB06 Glycopyrronium bromide

R03BB07 Umeclidinium bromide

R03BB54 Tiotropium bromide, combinations

R03BC Antiallergic agents, excluding corticosteroids

R03BC01 Cromoglicic acid

R03BC03 Nedocromil

R03BX Other drugs for obstructive airway diseases, inhalants

R03BX01 Fenspiride

R03C Adrenergics for systemic use

R03CA Alpha- and beta-adrenoreceptor agonists

R03CA02 Ephedrine

R03CB Non-selective beta-adrenoreceptor agonists

R03CB01 Isoprenaline

R03CB02 Methoxyphenamine

R03CB03 Orciprenaline

R03CB51 Isoprenaline, combinations

R03CB53 Orciprenaline, combinations

R03CC Selective beta-2-adrenoreceptor agonists

R03CC02 Salbutamol

R03CC03 Terbutaline

R03CC04 Fenoterol

R03CC05 Hexoprenaline

R03CC06 Isoetarine

R03CC07 Pirbuterol

R03CC08 Procaterol

R03CC09 Tretoquinol

R03CC10 Carbuterol

R03CC11 Tulobuterol

R03CC12 Bambuterol

R03CC13 Clenbuterol

R03CC14 Reproterol

R03CC53 Terbutaline, combinations

QR03CC90 Clenbuterol, combinations

R03D Other systemic drugs for obstructive airway diseases

R03DA Xanthines

R03DA01 Diprophylline

R03DA02 Choline theophyllinate

R03DA03 Proxyphylline

R03DA04 Theophylline

R03DA05 Aminophylline

R03DA06 Etamiphylline

R03DA07 Theobromine

R03DA08 Bamifylline

R03DA09 Acefylline piperazine

R03DA10 Bufylline

R03DA11 Doxofylline

R03DA20 Combinations of xanthines

R03DA51 Diprophylline, combinations

R03DA54 Theophylline, combinations excluding psycholeptics

R03DA55 Aminophylline, combinations

R03DA57 Theobromine, combinations

R03DA74 Theophylline, combinations with psycholeptics

R03DB Xanthines and adrenergics

R03DB01 Diprophylline and adrenergics

R03DB02 Choline theophyllinate and adrenergics

R03DB03 Proxyphylline and adrenergics

R03DB04 Theophylline and adrenergics

R03DB05 Aminophylline and adrenergics

R03DB06 Etamiphylline and adrenergics

R03DC Leukotriene receptor antagonists

R03DC01 Zafirlukast

R03DC02 Pranlukast

R03DC03 Montelukast

R03DC04 Ibudilast

R03DC53 Montelukast, combinations

R03DX Other systemic drugs for obstructive airway diseases

R03DX01 Amlexanox

R03DX02 Eprozinol

R03DX03 Fenspiride

R03DX05 Omalizumab

R03DX06 Seratrodast

R03DX07 Roflumilast

R03DX08 Reslizumab

References

↑ "ATC/DDD Index 2016: code R03". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2016: code QR03". WHO Collaborating Centre for Drug Statistics Methodology.

Drugs for obstructive airway diseases: asthma/COPD (R03)

Adrenergics, inhalants

Short-acting β₂ agonists	Bitolterol Carbuterol Fenoterol Isoetarine Pirbuterol Procaterol Reproterol Rimiterol Salbutamol (albuterol)^#/Levosalbutamol (levalbuterol) Terbutaline Tulobuterol

Long-acting β₂ agonists	Bambuterol Clenbuterol Formoterol/Arformoterol Salmeterol Salmefamol

Ultra-long-acting β₂ agonists	Abediterol Carmoterol Indacaterol Olodaterol Vilanterol

Other	Epinephrine^# Hexoprenaline Isoprenaline (isoproterenol) Orciprenaline (metaproterenol)

Glucocorticoids

Anticholinergics/
muscarinic antagonist

Mast cell stabilizers

Xanthines

Eicosanoid inhibition

Leukotriene antagonists	Montelukast Pranlukast Zafirlukast

Arachidonate 5-lipoxygenase inhibitors	Zileuton

Thromboxane receptor antagonists	Ramatroban Seratrodast

Non-xanthine PDE4 inhibitors	Ibudilast Roflumilast

Others/unknown

Combination products

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia - version of the 8/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.